Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-01-07 @ 1:41 PM
Study NCT ID:
NCT06073860
Status:
RECRUITING
Last Update Posted:
2024-11-06
First Post:
2023-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-21
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-03
First Submit QC Date:
None
Study First Post Date:
2023-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL